United States - English - NLM (National Library of Medicine)

l'oreal productos capilares - pyrithione zinc (unii: r953o2rhz5) (pyrithione zinc - unii:r953o2rhz5) - antidandruff - helps prevent recurrence of the symptoms of dandruff - helps eliminate scalp flaking and itching associated with dandruff

New Zealand - English - Medsafe (Medicines Safety Authority)

l'oreal new zealand limited - pyrithione zinc 0.1008%{relative} (as 48% solution) - shampoo - 0.1008% w/w - active: pyrithione zinc 0.1008%{relative} (as 48% solution) excipient: arginine aspartic acid bisabolol ethanol glutamic acid glycerol glyceryl polyacrylate glycine hydrolysed wheat protein magnesium sulfate nicotinamide perfume water

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - beeswax white - not applicable - 1mg/1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m loveridge ltd - beeswax white - not applicable - 1mg/1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - beeswax yellow - not applicable - 1mg/1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m loveridge ltd - beeswax yellow - not applicable - 1mg/1mg

Australia - English - Department of Health (Therapeutic Goods Administration)

raydel australia pty ltd - beeswax alcohols, quantity: 50 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; hypromellose; lactose monohydrate; maize starch; sodium starch glycollate - general well being anti-oxidant aids, assists and protects normal gastrointestinal functions may help in joint health.

Australia - English - Department of Health (Therapeutic Goods Administration)

ikaria australia pty ltd - methoxsalen, quantity: 0.2 mg - injection, concentrated - excipient ingredients: ethanol; glacial acetic acid; propylene glycol; sodium acetate trihydrate; sodium chloride; water for injections; sodium hydroxide - uvadex (methoxsalen) is indicated for extracorporeal administration with the therakos cellex photopheresis system for the: ? treatment of steroid-refractory and steroid-intolerant chronic graft versus host disease (cgvhd) in adults following allogeneic hsc transplantation. ? palliative treatment of the skin manifestations of cutaneous t-cell lymphoma (ctcl) that is unresponsive to other forms of treatment.

New Zealand - English - Medsafe (Medicines Safety Authority)

l'oreal new zealand limited - pyrithione zinc 0.9898%{relative} - shampoo - 0.9898% w/w - active: pyrithione zinc 0.9898%{relative} excipient: arginine aspartic acid bisabolol butyl hydroxybenzoate carbomer cetyl alcohol cocamidopropyl betaine coconut monoisopropanolamide dimeticone ethyl hydroxybenzoate glutamic acid glycerol glycine glydant hydrolysed wheat protein hydroxystearyl cetyl ehter hydroxypropyltrimonium methyl cocoate isobutyl hydroxybenzoate magnesium sulfate methyl hydroxybenzoate nicotinamide perfume polyquaternium-10 propyl hydroxybenzoate propylene glycol sodium chloride sodium cocoate sodium laureth sulfate sodium methyl hydroxybenzoate water

United States - English - NLM (National Library of Medicine)

l'oreal usa products inc - octinoxate 4%, titanium dioxide 3.6% - sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun on damaged or broken skin